Statnews
STAT (STAT News) is a Boston-based health, medicine and life sciences news organization founded in 2015, owned by Boston Globe Media. It publishes original reporting and sells a paid STAT+ subscription, proprietary research trackers, paid reports, events and branded content to life sciences professionals, policy stakeholders, institutional buyers and general readers.
- Company typePrivate
- Founded2015
- HeadquartersBoston, United States
- Headcount251–500
- GTM typeB2B and B2C
- OfferingDigital Commerce or Content
What Statnews does
STAT (published as STAT News) is a Boston-based, for-profit health, medicine and life sciences news organization founded in 2015 and operating under the Boston Globe Media umbrella. It produces original reporting, investigations and series across biotech, pharma, health tech, health insurance, hospitals, medical devices, health policy (FDA, NIH), science (CRISPR, gene therapy, neuroscience) and public health. Coverage is produced by specialist correspondents and reporters, including a Washington bureau (HHS and FDA reporters), a Europe correspondent and reporters covering biotech startups and venture capital. STAT sells primarily to three reader groups: life sciences and biopharma business professionals (biotech, pharma, health tech, investors), health policy and government stakeholders, and general readers interested in health and science, plus institutional buyers (hospitals, universities, libraries, life sciences companies). The company states it remains editorially independent and that its financial supporters — including Bloomberg Philanthropies, The Boston Foundation, The Commonwealth Fund, Dana Foundation, Greenwall Foundation, the Knight Science Journalism Program at MIT, NIHCM Foundation, Rise Together and the Robert Wood Johnson Foundation — are not involved in editorial decisions.\n\nThe core product is the STAT+ subscription, a tiered offering that gates in-depth analysis, exclusive reporting, newsletters, premium events, news alerts, podcasts and research reports, delivered on a WordPress-based publishing platform with paywall, account, billing and alert management, a mobile app, a reports storefront, an events platform, and analytics-driven personalization of the subscriber experience. Priced at $39/month, $399/year (advertised as 15% below twelve monthly payments), and a promotional starter tier of $30 for three months before reverting to $399/year, with cancel-anytime terms and discounts for students, educators and health care workers; group subscriptions run $300 per user per year self-serve for 2-10 users with request-a-quote contracts for 11+ users at savings starting at 25%. Four editorially maintained databases form the paid "Tools & Trackers" line: the CRISPR Tracker, the Breakthrough Device Tracker (described as an authoritative database of FDA fast-tracked devices), the Generative AI Tracker and the Obesity Drug Tracker, which covers dozens of weight-loss drugs in development.\n\nRevenue comes from five streams: recurring individual and group STAT+ subscriptions, one-off paid research reports (for example, "Chaotic and politicized: Inside the FDA under Trump" at $49, and the 2025 ranking of biotech's top venture capital firms) through reports.statnews.com, advertising and branded content via the in-house STAT Brand Studio, third-party content licensing (Muck Rack became the first communications platform to license STAT content, announced May 19, 2026) and reprints through Pars International, and a freemium funnel of free newsletters (Morning Rounds, The Readout, Pharmalittle, Pharmalot, D.C. Diagnosis, Readout LOUD, Lab Dish), podcasts (First Opinion, Color Code) and a weekday mini crossword. A dedicated senior vice president for growth & subscriptions and a chief operating officer sit alongside co-founder and executive editor Rick Berke. No revenue, subscriber count, funding history or cap-table data is disclosed in the supplied material.
Statnews firmographics
Firmographics- Name
- Statnews
- Legal name
- STAT
- Website
- https://statnews.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- STAT (STAT News) is a Boston-based health, medicine and life sciences news organization founded in 2015, owned by Boston Globe Media. It publishes original reporting and sells a paid STAT+ subscription, proprietary research trackers, paid reports, events and branded content to life sciences professionals, policy stakeholders, institutional buyers and general readers.
- Ownership category
- akta.pro rank
Statnews industry classification
Industry- Product category
- Digital Health and Life Sciences Media
- NAICS
- Periodical Publishers (513120), Newspaper, Periodical, Book, and Directory Publishers (5131), Directory and Mailing List Publishers (51314)
- SIC
- Newspapers: Publishing Or Publishing & Printing (2711)
- akta.pro industry
- Data Journalism & News Intelligence Publishers (Indexes, Election/Market Data)Media, Entertainment & Sports/Publishing (Books, News, Magazines)/News Publishing (Newspapers, Digital Newsrooms, Wire Services)Health, Wellness & Fitness Trade PublishingMedia, Entertainment & Sports/Publishing (Books, News, Magazines)/Book Publishing (Trade & Consumer)Health, Fitness & Wellness MagazinesMedia, Entertainment & Sports/Publishing (Books, News, Magazines)/Magazine Publishing (Consumer & B2B/Trade Magazines)
Keywords
Where Statnews is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Statnews business model
Business model- GTM type
- B2B and B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- STAT+ individual subscriptions: Paid access to exclusive reporting, analysis, newsletters, premium events and alerts for individual readers; monthly and annual billing with a promotional starter tier and cancel-anytime terms. Annual plan priced at $399 versus $468 for twelve monthly payments (15% saving).
- STAT+ group subscriptions: Organization-wide access for teams: self-serve annual seats at $300 per user for 2-10 users and custom-priced contracts for 11+ users with savings starting at 25%, typically sold to hospitals, universities, libraries and life sciences companies.
- Paid research reports (STAT Reports): One-off sales of long-form data-and-analysis reports through the reports.statnews.com storefront, e.g. 'Chaotic and politicized: Inside the FDA under Trump' at $49, alongside rankings such as the 2025 edition ranking biotech's top venture capital firms.
- Advertising and branded content: Sponsored content and advertising, including a dedicated in-house brand studio (STAT Brand Studio) that creates branded assets for sponsors, supported by an 'Advertise With Us' offering.
- Content licensing: Licensing of STAT journalism to third-party communications platforms; Muck Rack became the first communications platform to license STAT content.
- Free newsletters and podcasts (acquisition funnel): Free daily and weekly newsletters (Morning Rounds, The Readout, Readout LOUD, Pharmalittle, Pharmalot, D.C. Diagnosis, Lab Dish) and free podcasts that build the audience funnel into paid STAT+ subscriptions rather than direct revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Individual monthly STAT+ plan |
| Subscription | Annual | Starter promotional annual plan |
| Subscription | Annual | Individual annual STAT+ plan |
| Per seat | Annual | Group subscription, 2-10 users |
| Per seat | Annual | Group subscription, 11+ users |
| Unit Pricing | One time/ perpetual license | Individual paid research report |
Go-to-market motion5 records
Distribution channels7 records
Marketing channels9 records
Statnews product offering
Product offeringCore offering
STAT (STAT News) is a Boston-based news organization founded in 2015 and published by Boston Globe Media that produces journalism about health, medicine and the life sciences, including daily news, investigative series, policy coverage, newsletters, podcasts, video and paid research reports. Its core commercial offering is the "STAT+" paid subscription ($39/month or $399/year for individuals; $300 per user annually for 2-10 user group seats with custom pricing for 11+ users), which unlocks exclusive reporting, in-depth analysis, subscriber-only newsletters, premium events, news alerts and research trackers. Monetization is supplemented by advertising and an in-house branded-content studio (STAT Brand Studio), one-off paid research reports sold through reports.statnews.com (e.g., "Chaotic and politicized: Inside the FDA under Trump" at $49), in-person events such as the annual STAT Summit, and third-party content licensing (e.g., to Muck Rack).
Product overview
STAT News operates a hybrid publishing model: a free, advertising-supported news and analysis platform (news, topics and coverage areas such as Biotech, Pharma, Health Tech, Policy and Science) built around the paid "STAT+" subscription, which bundles premium reporting with a set of modular add-on tools — the STAT Reports line, the "Tools & Trackers" database modules (CRISPR Tracker, Breakthrough Device Tracker, Generative AI Tracker, Obesity Drug Tracker), the newsletter suite (Morning Rounds, The Readout, Pharmalittle, Pharmalot, D.C. Diagnosis, Lab Dish, Color Code), the podcast suite (The Readout LOUD, First Opinion, Color Code, Lab Dish) and premium events such as the STAT Summit — plus engagement products (the STAT Mini crossword, the STAT App, the STAT video channel, Shop STAT), advertising/brand services through STAT Brand Studio, and a content licensing/reprints business operated with Pars International.
Differentiator
Problem solved
Functional benefit
Brands
- STAT+: STAT's paid subscription offering for in-depth analysis, newsletters, premium events and news alerts, sold as monthly ($39), annual ($399) and group plans.
- STAT Reports
- STAT Brand Studio
- STAT Events
- STAT Wunderkinds
- STAT Trackers
- STAT App
- Pharmalot / Pharmalittle
- D.C. Diagnosis
- The Readout
- The Readout LOUD
- Morning Rounds
- First Opinion
- Lab Dish
- Color Code
- STATus Report
Products and services
- STAT+ STAT's premium paid subscription tier giving individual readers access to exclusive reporting, in-depth analysis, subscriber newsletters, premium events, news alerts, podcasts and research reports; priced at $39/month or $399/year, with group subscriptions from $300 per user annually, cancel-anytime terms, and discounted plans for students, educators and health care workers.
- STAT Reports One-off paid research reports blending quantitative data insights with qualitative reporting on pivotal life sciences topics, sold individually through the reports.statnews.com storefront (e.g., 'Chaotic and politicized: Inside the FDA under Trump' at $49).
- CRISPR Tracker Tool and tracker that follows the latest developments in genome editing, part of STAT's 'Tools & Trackers' line of curated research databases.
- Breakthrough Device Tracker An authoritative database of the FDA's fast-tracked (breakthrough designation) medical devices, offered under the STAT+ subscription tier.
- Generative AI Tracker A guide to the health systems and companies driving adoption of generative AI in health care, offered under the STAT+ subscription tier.
- Obesity Drug Tracker Curated tracker covering the dozens of weight-loss drugs in development, helping readers follow a fast-growing market; part of STAT's Tools & Trackers line.
- STAT Newsletters Email newsletter portfolio including Morning Rounds (daily), The Readout (biotech), Pharmalittle and Pharmalot (pharma), D.C. Diagnosis (health policy, twice-weekly), Lab Dish, First Opinion and Color Code; free signups with subscriber-only upgrades that feed the STAT+ funnel.
- STAT Podcasts Podcast suite covering policy to practice, including The Readout LOUD (weekly biotech podcast), First Opinion Podcast (interviews with people and ideas in medicine), Color Code (racial inequities in American health care) and Lab Dish (science and bioethics).
- STAT Events Portfolio of in-person and virtual events throughout the year, including the annual 2026 STAT Summit in Boston, MA, and virtual recaps such as the AAIC Recap on Alzheimer's; subscriber events feed the STAT+ subscription funnel.
- STAT Brand Studio In-house brand studio (sbs.statnews.com) providing advertising and branded content opportunities to sponsors, producing custom branded assets for health and science audiences.
- STAT Content Licensing and Reprints Licensing and reprint service allowing other publications to republish STAT journalism, handled through Pars International; STAT content was also licensed to Muck Rack, the first communications platform to license STAT content (announced May 19, 2026).
- STAT App Official mobile application providing access to STAT's journalism, newsletters and STAT+ content on mobile.
- STAT Mini Crossword Weekday mini crossword game on the site that tests readers' knowledge of health and science news and drives habitual daily engagement.
- STAT Video Video channel publishing status-report explainers (e.g., 'What's next for GLP-1 weight loss drugs?'), conference coverage such as BIO 2026 and interview features.
- Shop STAT Official STAT-branded merchandise collection fulfilled through the Boston Globe Media online storefront (store.bostonglobe.com).
Companies that use Statnews
Customer profileSegments5 records
Ideal customer profiles6 records
Statnews technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability4 records
Feature7 records
Statnews partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered strategic licensing deal — first of its kind for stat content and supporting distribution partner.
- Muck Rackstrategic licensing deal — first of its kind for stat contentMuck Rack became the first communications platform to license STAT content, extending STAT's journalism into communications/PR tooling and platforms. The announcement positions STAT content as licensable alongside other premium communications content.
- Pars Internationalsupporting distribution partnerPars International handles STAT reprints and licensing of stories via its publications page for STAT (parsintl.com/publications/stat), extending reuse of STAT journalism for institutional and commercial reprint customers.
Scale indicators5 records
Recent moves6 records
Expansion highlights8 records
Statnews competitors and assessment
Company assessmentDirect peers
- Endpoints News (Endpoints): Endpoints is a subscription business-news outlet covering biotech R&D, pharma deals, FDA and venture funding with a metered paywall and paid newsletters. It competes directly with STAT for the same life sciences decision-maker audience and subscription budget.
- BioPharma Dive: BioPharma Dive publishes free daily biotech and pharma news with email newsletters and sponsored campaigns, matching STAT's free-to-paid funnel structure in the same regulatory and drug-development beat.
- Fierce Biotech: Fierce Biotech is a vertical publication covering drug development and devices with free articles, newsletters, events and advertising, competing head-to-head with STAT for biotech subscribers and pharma advertising budgets.
- Medtech Dive: Medtech Dive covers medical devices, health tech and hospital business with free newsletters and sponsored content — the same device, health-tech and hospital categories that STAT serves as a subscription vertical.
- BioCentury: BioCentury is a paid biotech business-intelligence and news platform delivering analysis, deal data and rankings to biotech investors and executives, closely analogous to STAT+ premium reporting and paid reports.
- Healthcare Dive: Healthcare Dive covers health systems, insurers and health policy for a business audience using free news, newsletters and industry events, overlapping STAT's Policy, Hospitals and Health Insurance coverage areas.
Broad incumbents
- BioWorld: BioWorld is an established, subscription-led biotech news and intelligence service that sits inside a larger information-provider group. It is comparable as a paid vertical-news business model with deep industry data products.
- Medscape: Medscape combines health news and medical reference content with physician tools and advertising, serving clinicians and industry readers that overlap with STAT's professional audience while operating a broader portfolio.
- The Boston Globe: The Boston Globe is STAT's parent publication under Boston Globe Media, sharing infrastructure, the group store and the corporate umbrella, and competing for the same general reader advertising market.
Others
- Muck Rack (Cision): Muck Rack is a PR and communications platform that became the first licensed distributor of STAT content. It is a commercial partner and a potential competitor for comms budgets, illustrating how premium journalism is packaged as licensed media assets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat8 records
Key risks6 records
Key highlights7 records
Customer concentration
Statnews social profiles
Digital presenceStatnews compliance and trust
Trust signalCompliance2 records
Statnews financial estimates
Financial estimateRevenue estimate
Valuation estimate
Statnews leadership team
Management profileNumber of profiles
Profiles9 records
Statnews funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Statnews M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Statnews
What does Statnews do?
STAT (STAT News) is a Boston-based news organization founded in 2015 and published by Boston Globe Media that produces journalism about health, medicine and the life sciences, including daily news, investigative series, policy coverage, newsletters, podcasts, video and paid research reports. Its core commercial offering is the "STAT+" paid subscription ($39/month or $399/year for individuals; $300 per user annually for 2-10 user group seats with custom pricing for 11+ users), which unlocks exclusive reporting, in-depth analysis, subscriber-only newsletters, premium events, news alerts and research trackers. Monetization is supplemented by advertising and an in-house branded-content studio (STAT Brand Studio), one-off paid research reports sold through reports.statnews.com (e.g., "Chaotic and politicized: Inside the FDA under Trump" at $49), in-person events such as the annual STAT Summit, and third-party content licensing (e.g., to Muck Rack).
Is Statnews a public or private company?
Statnews is a private company. It is classified as corporate owned and is currently operating.
When was Statnews founded?
Statnews was founded in 2015. It employs 251 to 500 people.
Where is Statnews based?
Statnews is headquartered in Boston, United States, in the North America region.
How does Statnews make money?
Six revenue lines are on record. STAT+ individual subscriptions are the primary driver. The others are STAT+ group subscriptions, paid research reports (STAT Reports), advertising and branded content, content licensing and free newsletters and podcasts (acquisition funnel).
Who are Statnews's main competitors?
Direct peers on record are Endpoints News (Endpoints), BioPharma Dive, Fierce Biotech, Medtech Dive, BioCentury and Healthcare Dive. Broad incumbents are BioWorld, Medscape and The Boston Globe. Muck Rack (Cision) is listed as an others.
Does Statnews have an API?
No public API is recorded for Statnews.
What industry is Statnews in?
Statnews's product category is Digital Health and Life Sciences Media. Its primary akta.pro industry code is MPAJADAK, Data Journalism & News Intelligence Publishers (Indexes, Election/Market Data), with a secondary code of MPAJAAAL, Health, Wellness & Fitness Trade Publishing. Its NAICS code is 513120 and its SIC code is 2711.